Loading…
Clinical Quality Oversight has ended
Back To Schedule
Wednesday, September 29 • 9:30am - 10:00am
TRACK A: RBQM and Centralized Monitoring - Pfizer's COVID-19 Vaccine Development

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
How the use of RBQM and Centralized Monitoring Enabled Pfizer's Lightspeed Covid-19 Vaccine Development
  • Understand how and why RBQM principles and centralized monitoring were applied to the Pfizer Covid-19 vaccine program
  • Review key take-aways to inform RBQM centralized monitoring best practices moving forward
Speakers
avatar for Lynne Cesario

Lynne Cesario

Senior Director, Global Risk-Based Monitoring Program Lead, PFIZER
Lynne Cesario has more than 24 years of experience in clinical research and drug development in the pharmaceutical industry. She is currently a Senior Director in the Data Monitoring and Management department, leading the Global Risk Based Monitoring Program at Pfizer. As the overall... Read More →
avatar for Steve Young

Steve Young

Chief Scientific Officer, CLUEPOINTS
As CSO, Steve oversees the research and development of advanced methods for the CluePoints platform, along with providing RBQM methodology guidance to customers.  Steve worked in clinical data management over a span of 15 years, and has since focused on leading the development of... Read More →

Wednesday September 29, 2021 9:30am - 10:00am EDT
  Track A - In-Person Only